Prognostic role of neutrophil-tolymphocyte ratio in solid tumors: a systematic review and meta-analysis, J. Natl. Cancer Inst, vol.106, p.124, 2014. ,
DOI : 10.1093/jnci/dju124
Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer, Journal of Surgical Oncology, vol.23, issue.3, pp.181-184, 2005. ,
DOI : 10.1097/00000421-200006000-00011
The prognostic impact of the neutrophil-to-lymphocyte ratio in patients with small-cell lung cancer, British Journal of Cancer, vol.17, issue.3, pp.452-460, 2014. ,
DOI : 10.1159/000127412
Neutrophil-to-lymphocyte ratio: could it be used in the clinic as prognostic marker for gastrointestinal stromal tumor? Hepatogastroenterology, pp.1649-1653, 2014. ,
Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Primary Liver Cancer: A Meta-Analysis, PLoS ONE, vol.14, issue.7, p.96072, 2014. ,
DOI : 10.1371/journal.pone.0096072.s007
Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment, Cancer Immunology, Immunotherapy, vol.23, issue.25, pp.15-23, 2008. ,
DOI : 10.1164/ajrccm.159.3.9805087
Subclassification of upper urinary tract urothelial carcinoma by the neutrophil-to-lymphocyte ratio (NLR) improves prediction of oncological outcome, BJU International, vol.121, issue.5b, pp.144-149, 2014. ,
DOI : 10.1111/j.1365-2567.2007.02587.x
Pretreatment Neutrophil to Lymphocyte Ratio as a Prognostic Predictor of Urologic Tumors, Medicine, vol.94, issue.40, p.1670, 2015. ,
DOI : 10.1097/MD.0000000000001670
URL : http://doi.org/10.1097/md.0000000000001670
EAU Guidelines on Renal Cell Carcinoma: 2014 Update, European Urology, vol.67, issue.5, pp.913-924, 2015. ,
DOI : 10.1016/j.eururo.2015.01.005
URL : https://hal.archives-ouvertes.fr/hal-01260564
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor???Targeted Agents: Results From a Large, Multicenter Study, Journal of Clinical Oncology, vol.27, issue.34, pp.5794-5799, 2009. ,
DOI : 10.1200/JCO.2008.21.4809
Clinico-pathological prognostic factors of renal cell carcinoma: A 15-year review from a single center in Greece, Urology Annals, vol.6, issue.2, pp.116-121, 2014. ,
DOI : 10.4103/0974-7796.130552
Prognostic Impact of Preoperative Neutrophil-to-Lymphocyte Ratio in Localized Nonclear Cell Renal Cell Carcinoma, The Journal of Urology, vol.190, issue.6, pp.1999-2004, 2013. ,
DOI : 10.1016/j.juro.2013.06.082
Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma, The Journal of Urology, vol.187, issue.2, pp.411-417, 2012. ,
DOI : 10.1016/j.juro.2011.10.026
Is the Pretreatment Neutrophil to Lymphocyte Ratio an Important Prognostic Parameter in Patients with Metastatic Renal Cell Carcinoma?, Clinical Genitourinary Cancer, vol.11, issue.2, pp.141-148, 2013. ,
DOI : 10.1016/j.clgc.2012.09.001
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer, British Journal of Cancer, vol.102, issue.1, pp.147-153, 2013. ,
DOI : 10.1159/000127412
URL : http://www.nature.com/bjc/journal/v109/n1/pdf/bjc2013300a.pdf
Followup of Neutrophil-to-Lymphocyte Ratio and Recurrence of Clear Cell Renal Cell Carcinoma, The Journal of Urology, vol.187, issue.2, pp.411-417, 2012. ,
DOI : 10.1016/j.juro.2011.10.026
Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center, BMC Urology, vol.59, issue.6, p.47, 2013. ,
DOI : 10.1016/j.eururo.2011.02.032
Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma, British Journal of Cancer, vol.109, issue.7, pp.1755-1759, 2013. ,
DOI : 10.1200/JCO.2006.08.3774
URL : http://www.nature.com/bjc/journal/v109/n7/pdf/bjc2013522a.pdf
Comprehensive analysis and validation of contemporary survival prognosticators in Korean patients with metastatic renal cell carcinoma treated with targeted therapy: prognostic impact of pretreatment neutrophil-to-lymphocyte ratio, International Urology and Nephrology, vol.171, issue.6, 2016. ,
DOI : 10.1097/01.ju.0000110610.61545.ae